Locally Advanced Cervical Carcinoma

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Akesobio
AkesobioChina - Zhongshan
1 program
1
standard EBRT+BrachytherapyPhase 31 trial
Active Trials
NCT07400536Not Yet Recruiting378Est. Jul 2032

Trial Timeline

Clinical trial activity over time

2026
2027
2028
2029
2030
2031
Akesobiostandard EBRT+Brachytherapy

Clinical Trials (1)

Total enrollment: 378 patients across 1 trials

NCT07400536Akesobiostandard EBRT+Brachytherapy

A Clinical Study on the Treatment of LACC With Cadonilimab Combined With Chemotherapy Followed by CCRT

Start: Mar 2026Est. completion: Jul 2032378 patients
Phase 3Not Yet Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space